Moberg Pharma AB

Moberg Pharma AB
Stock Exchange OTC Publication Venue
EPS
SEK1.49
Market Cap
SEK1.17 B
Shares Outstanding
17.7 M
Public Float
14.33 M

Profile

Address
Gustavslundsvägen 42, 5 tr
Bromma AB 167 51
Sweden
Employees -
Website http://www.mobergpharma.se
Updated 07/08/2019
Moberg Pharma AB is a pharmaceutical company, which engages in the development and commercialization of medical products. It offers its products through the following brands: Kerasal, Kerasal Nail, Balmex, NewSkin, Dermoplast, Domeboro, and Fiber Choice. The company was founded by Peter Gunnar Maurits Wolpert and Marie Moberg in March 2006 and is headquartered in Bromma, Sweden.

Financials

View All

Anna Yvonne Monica Malm Bernsten
Director
Sara Catherine Brandt
Director